The DOI matches its Crossref record.
Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England
Open accessAbstract
Summary Background: Analysis of primary healthcare datasets offers the possibility to increase understanding of the epidemiology of acute uncommon conditions such as anaphylaxis, but these datasets remain under-exploited. Aim: To investigate recent trends in the recorded incidence, lifetime prevalence and prescribing of adrenaline for anaphylaxis in England. Methods: QRESEARCH is one of the world's largest national aggregated health databases containing the records of over nine million patients. We extracted data on all patients with a recorded diagnosis of anaphylaxis and calculated annual age-sex standardized incidence and lifetime period prevalence rates for each year from 2001–2005. We also analysed trends in adrenaline prescribing in those with a recorded diagnosis of anaphylaxis. National population figures were used to estimate numbers of people in England that have experienced anaphylaxis at some point in their lives. Results: The age-sex standardized incidence of anaphylaxis was 6.7 per 100,000 person-years in 2001 and increased by 19% to 7.9 in 2005. Lifetime age-sex standardized prevalence of a recorded diagnosis of anaphylaxis was 50.0 per 100,000 in 2001 and increased by 51% to 75.5 in 2005. Prescribing of adrenaline increased by 97% over this period. By the end of 2005 there were an estimated 37,800 people that had experienced anaphylaxis at some point in their lives. Conclusions: Recorded incidence, lifetime prevalence and prescribing of adrenaline for anaphylaxis all showed substantial increases in recent years. An estimated 1 in 1,333 of the English population have at some point in their lives experienced anaphylaxis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
World Allergy Organization Guidelines for the Assessment and Management of Anaphylaxis
Simons, F. E. R., Ardusso, L. R. F., Bilò, M. B., El-Gamal, Y. M., Ledford, D. K., Ring, J., Sanchez-Borges, M., Senna, G. E., Sheikh, A., & Thong, B. Y. (2011) · World Allergy Organization Journal · doi:10.1097/wox.0b013e318211496c · Cited by 973
Self-citationWorld Allergy Organization anaphylaxis guidelines: Summary
Simons, F. E. R., Ardusso, L. R. F., Bilò, M. B., El-Gamal, Y. M., Ledford, D. K., Ring, J., Sanchez-Borges, M., Senna, G. E., Sheikh, A., & Thong, B. Y. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.01.038 · Cited by 570
Self-citationThe epidemiology of anaphylaxis in Europe: a systematic review
Panesar, S. S., Javad, S., de Silva, D., Nwaru, B. I., Hickstein, L., Muraro, A., Roberts, G., Worm, M., Bilò, M. B., Cardona, V., et al. (2013) · Allergy · doi:10.1111/all.12272 · Cited by 417
Self-citationEmergency treatment of anaphylactic reactions—Guidelines for healthcare providers
Soar, J., Pumphrey, R., Cant, A., Clarke, S., Corbett, A., Dawson, P., Ewan, P., Foëx, B., Gabbott, D., Griffiths, M., et al. (2008) · Resuscitation · doi:10.1016/j.resuscitation.2008.02.001 · Cited by 399
Self-citationAnaphylaxis in America: The prevalence and characteristics of anaphylaxis in the United States
Wood, R. A., Camargo, C. A., Lieberman, P., Sampson, H. A., Schwartz, L. B., Zitt, M., Collins, C., Tringale, M., Wilkinson, M., Boyle, J., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.08.016 · Cited by 394
Metadata
- Authors
- Sheikh, A., Hippisley-Cox, J., Newton, J., & Fenty, J.
- Venue
- Journal of the Royal Society of Medicine
- Publisher
- SAGE Publications
- Published
- 2008-03-01
- Volume
- 101
- Issue
- 3
- Pages
- 139-143
- ISSN
- 0141-0768 (ISSN-L)
- 1758-1095
- OpenAlex
- W2116073463
- Cited by
- 171
- References
- 0
- FWCI
- 9.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England. https://app.cochat.ai/papers/10.1258/jrsm.2008.070306
- The paper
- Sheikh, A., Hippisley-Cox, J., Newton, J., & Fenty, J. (2008). Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England. Journal of the Royal Society of Medicine. https://doi.org/10.1258/jrsm.2008.070306
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.